Become a member to receive our newsletter and get unrestricted access to downloadable slidekits...
A confirmation email has been sent to
Please click on the Activation Link to activate your account.
If you don't receive our email, please check your spam folder.
Already registered?
Neved registered?
Forgot your codes?
In this report, 11,140 type 2 diabetes patients were followed for a median of 5.0 (in-trial), 5.4 (post-trial), and 9.9 (overall) years. Overall, 516 (4.6%) patients had major peripheral arterial disease at baseline; 300 (2.7%) had lower-extremity chronic ulceration or amputation alone, 190 (1.7%) had peripheral revascularization alone, and 26 (0.2%) had both presentations. Over the follow-up period, 2265 (20.3%) died (all causes), 2166 (19.4%) had major cardiovascular events of whom 988 (8.9%) died, and 807 (7.2%) had major clinical microvascular events. Overall, major peripheral artery disease was associated with 35% (15-60%) increased risk of death (p = 0.0004), 47% (23-75%) increased risk of major cardiovascular events (p <0.0001), 75% (39-221%) increased risk of cardiovascular death (p < 0.0001), and 58% (19-209%) increased risk of myocardial infarction (p = 0.001). There was also a trend toward an association between baseline peripheral artery disease and risk of major clinical microvascular events [hazard ratio 1.31, 95% CI 0.96–1.78, p = 0.09], specifically diabetic retinopathy. In conclusion, these findings emphasize that type 2 diabetes patients with major peripheral artery disease have poor survival and cardiovascular outcomes and underline the need for routine screening for peripheral artery disease to improve prognosis.